MedDataX Logo

Hemofiltration for Contrast-Induced Nephropathy

NCT ID: NCT00158080

Last Updated: 2005-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease Cardiac Catheterization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hemofiltration

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with serum creatinine\>2.0mg/dl and/or GFR\<50ml/min

Exclusion Criteria

* Emergent cardiac catheterization
* Patients on chronic dialysis
* Patients with HYHA\>III heart failure
Minimum Eligible Age

20 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nara Medical University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yoshihiko Saito, MD, PhD

Role: STUDY_DIRECTOR

Nara Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

First Dept of InternalMedicine, Nara Medical University

Kashihara, Nara, Japan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Japan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Koji Harada, MD

Role: CONTACT

Phone: +81-744-22-3051

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Koji Harada, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Kashyap AS, Anand KP, Kashyap S. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. N Engl J Med. 2004 Feb 19;350(8):836-8; author reply 836-8. No abstract available.

Reference Type BACKGROUND
PMID: 14978842 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K0001

Identifier Type: -

Identifier Source: org_study_id